Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if azacitidine combined with Chidamide
will help to control the disease in patients with high-risk AML after an allogeneic stem cell
transplant. The safety of this combination will also be studied.